fluciclovine-f-18 has been researched along with Carcinoma--Hepatocellular* in 1 studies
1 other study(ies) available for fluciclovine-f-18 and Carcinoma--Hepatocellular
| Article | Year |
|---|---|
18F-Fluciclovine Uptake by an Incidentally Detected Hepatocellular Carcinoma in a Case of Biochemically Recurrent Prostate Cancer.
Prostate cancer is one of the most common cancers affecting men worldwide with a high recurrence rate following therapy. F-fluciclovine, is a US Food and Drug Administration-approved radiopharmaceutical for PET imaging in biochemically recurrent prostate cancer. It targets increased amino acid transporters in the cell membrane of cancer cells. We report a case of incidentally detected hepatocellular carcinoma showing F-fluciclovine uptake in a 71-year-old man with biochemically recurrent prostate cancer. Topics: Aged; Biological Transport; Carboxylic Acids; Carcinoma, Hepatocellular; Cyclobutanes; Humans; Incidental Findings; Liver Neoplasms; Male; Positron Emission Tomography Computed Tomography; Prostatic Neoplasms | 2018 |